Position history for VANGUARD GROUP INC's holdings in CRINETICS PHARMACEUTICALS IN
VANGUARD GROUP INC holds 9.1M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $425.3M as of 2025-Q4. The position was decreased (-0.4% shares). CRNX represents 0.0% of VANGUARD GROUP INC's portfolio.
Current Value
$425.3M
Current Shares
9.1M
Total Value Change
+$104M
Total Shares Change
+2.8M
Other major holders of CRNX: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 9.1M |
-0.4% |
| $425.3M |
| 0.0% |
| $47.39 |
0 |
| 2025-Q3 | Decreased | 9.2M | -0.9% | $381.9M | 0.0% | $43.51 | 0 |
| 2025-Q2 | Decreased | 9.3M | -0.6% | $266.2M | 0.0% | $29.96 | 0 |
| 2025-Q1 | Increased | 9.3M | +2.4% | $312.3M | 0.0% | $34.73 | 32 |
| 2024-Q4 | Increased | 9.1M | +44.6% | $464.7M | 0.0% | $50.67 | 42 |
| 2024-Q3 | New | 6.3M | - | $321.3M | 0.0% | $50.75 | 43 |